Pemphigus Vulgaris and Bullous Pemphigoid

Pemphigus vulgaris (PV) and bullous pemphigoid (BP) are the two most common autoimmune blistering disorders affecting the skin and mucous membranes. PV is characterized by intraepidermal acantholysis (loss of cell-to-cell adhesion) caused by autoantibodies against desmoglein 3 (and often desmoglein 1), while BP results from subepidermal blistering due to autoantibodies against hemidesmosomes (BP180 and BP230 antigens). Both conditions have significant morbidity if untreated, with mortality rates historically approaching 10% in untreated PV, though modern immunosuppressive therapy has dramatically improved outcomes. PV typically affects middle-aged to older adults (peak age 40-60 years), while BP predominantly presents in elderly patients (>60 years), making both conditions important in geriatric dermatology practice. Understanding the pathophysiologic differences between these conditions is critical for accurate diagnosis and appropriate therapeutic selection on board examinations and in clinical practice.

The fundamental pathophysiology of PV centers on loss of cell-to-cell adhesion within the epidermis secondary to autoimmune attack on desmosomal components. Patients develop IgG autoantibodies (predominantly IgG1 and IgG3 subclasses) directed against desmoglein 3 (Dsg3), a transmembrane glycoprotein that is a critical component of desmosomes—the anchoring junctions that maintain epidermal cohesion. In approximately 50% of PV patients, additional antibodies against desmoglein 1 (Dsg1) are also present. These pathogenic IgG antibodies bind to desmogleins on the surface of keratinocytes, triggering several downstream mechanisms: (1) direct blockade of Dsg3-Dsg1 adhesive interactions; (2) activation of c-src and Rho family GTPases through cross-linking of desmogleins, leading to disruption of actin-myosin networks; and (3) complement-independent activation of p38 mitogen-activated protein kinase (MAPK) signaling, which increases intracellular calcium and promotes keratinocyte apoptosis. This results in suprabasal acantholysis, creating intraepidermal blisters that characteristically spare the basal cell layer, which remains attached to the basement membrane via hemidesmosomes (producing the "tombstone" appearance on histology with a row of basaloid cells lining the blister floor).

The "desmoglein compensation theory" explains important clinical correlations in PV: when only anti-Dsg3 antibodies are present (typically in mucosal-dominant disease), mucosal membranes blister preferentially because they express primarily Dsg3; however, Dsg1 in the superficial epidermis can partially compensate, limiting skin manifestations. In mucocutaneous disease, the presence of additional anti-Dsg1 antibodies overwhelms compensation mechanisms, causing widespread cutaneous blistering in addition to mucosal involvement.

In contrast to PV, BP pathophysiology involves autoimmune destruction of hemidesmosomes—the anchoring complexes at the dermal-epidermal junction that attach the basal epithelium to the basement membrane zone (BMZ). The primary autoantigens are BP180 (collagen XVII) and BP230 (BPAG3), both integral to hemidesmosomal structure. Pathogenic IgG autoantibodies (predominantly IgG4 and IgG1 subclasses) bind these antigens, triggering classical complement activation (C1q binding and C3 deposition) that activates the complement cascade locally. This leads to recruitment and degranulation of mast cells and neutrophils, which release elastase, collagenase, and other proteolytic enzymes that degrade BP180 and the sub-basal lamina anchoring structures. Additionally, antibody-mediated crosslinking of BP180 dimers activates phospholipase C and increases intracellular calcium in basal keratinocytes, promoting cell contraction and mechanical separation from the basement membrane. The resulting subepidermal blister is lined inferiorly by intact basement membrane and superiorly by the entire epidermis (contrast with PV), and the blister fluid characteristically contains abundant eosinophils due to recruitment by complement-derived chemoattractants.

Both PV and BP demonstrate strong associations with HLA alleles: PV is associated with HLA-DRB1*04 (particularly in Ashkenazi Jewish patients) and HLA-DQ1, while BP shows associations with HLA-DQ7 in European populations. These HLA associations suggest T cell-mediated autoimmunity drives the development of pathogenic B cell clones producing anti-desmogleins and anti-hemidesmosomal antibodies. Environmental triggers including infections (particularly herpes simplex virus and varicella-zoster virus in PV), medications (ACE inhibitors, penicillamine, NSAIDs), and UV exposure have been implicated in precipitating disease or exacerbations, likely through molecular mimicry or epitope spreading mechanisms.

PV is a primary autoimmune disorder with no clearly identified single causative agent, though multiple genetic and environmental factors contribute. HLA associations are the strongest genetic risk factors, with HLA-DRB1*04 conferring the highest relative risk, particularly in Ashkenazi Jewish populations (25-30% of US PV patients). Jewish ancestry (Ashkenazi heritage) is a classic demographic risk factor, with incidence rates 5-10 fold higher than in general populations. Age represents the most consistent epidemiologic pattern, with peak incidence in the 5th-6th decades, though all ages can be affected. Infectious triggers have been implicated, with herpes simplex virus (HSV) and varicella-zoster virus (VZV) as the most well-documented associations; some patients report disease onset or exacerbation following herpetic infections. Medications including penicillamine (used for Wilson's disease and rheumatoid arthritis), ACE inhibitors (captopril, enalapril), NSAIDs, and phenothiazines have been reported as precipitants, though causality remains variable. Ultraviolet light exposure may trigger disease in genetically predisposed individuals. Paraneoplastic pemphigus is a distinct variant associated with underlying malignancy (lymphoproliferative disorders in 90% of cases), though this differs histopathologically from classical PV.

In contrast to PV, BP is not strongly associated with ethnic heritage and occurs across all racial and ethnic groups at roughly similar rates. Advanced age is the predominant risk factor, with 90% of BP cases occurring in patients >60 years old; the incidence increases dramatically with each decade after age 50. Medications represent a well-established trigger for BP: diuretics (particularly thiazides and furosemides) account for 20-40% of drug-induced BP cases; ACE inhibitors (captopril, enalapril, lisinopril); NSAIDs; antibiotics (penicillins, tetracyclines); antimalarial agents (hydroxychloroquine); and topical retinoids have all been implicated. The mechanism in drug-induced BP may involve drug-protein conjugation creating new epitopes, molecular mimicry, or polyclonal B cell activation. Physical trauma and infection (viral and bacterial) can precipitate or exacerbate BP. Underlying malignancy is less frequently associated with BP than with PV, but associations with gastric carcinoma, lymphoproliferative disorders, and other cancers have been documented. Neurologic comorbidities including Parkinson's disease, dementia, and cerebrovascular disease have been noted in some series, possibly reflecting shared pathogenic mechanisms or simply the advanced age cohort affected.

The classic presentation of PV begins with painful oral ulcers that may be the sole manifestation for weeks to months before cutaneous disease appears (oral involvement precedes skin lesions in 50-90% of cases). These mucosal erosions are typically ill-defined, friable, painful, and slow to heal, involving the buccal mucosa, hard and soft palate, gingiva, and tongue. Patients often report difficulty eating, drinking, and speaking due to severe pain. The positive Nikolsky sign—wherein gentle lateral pressure or rubbing of apparently normal mucosa or skin results in epidermal separation and blister formation—is a pathognomonic finding that reflects the underlying acantholysis; this sign is present in most PV patients and is a critical bedside finding for diagnosis.

As disease progresses, flaccid blisters and erosions appear on the skin, typically beginning on the face, scalp, and intertriginous areas before potentially spreading to become generalized. The blisters are fragile and rupture easily, leaving painful erosions with ragged margins and surrounding erythema. In contrast to bullous pemphigoid, the blisters in PV are thin-walled and poorly demarcated, contain clear fluid (with variable turbidity), and lack the violaceous halo. The erosions are the predominant clinical finding rather than intact blisters because of the blisters' extreme fragility; these erosions may appear crusted, weeping, or secondarily infected. Patients report severe burning pain and pruritus that are often disproportionate to the extent of visible disease, reflecting the inflammatory milieu in the epidermis.

Important Clinical Variants demonstrate the spectrum of PV phenotypes: (1) Mucosal-dominant PV presents with isolated oral and/or esophageal involvement without skin disease in ~20% of cases; these patients possess anti-Dsg3 antibodies only; (2) Mucocutaneous PV (classic presentation) combines mucosal ulceration with cutaneous blistering and erosions, typically with both anti-Dsg3 and anti-Dsg1 antibodies; (3) Cutaneous-dominant PV (rare) presents with primarily superficial blistering resembling pemphigus foliaceus; (4) Paraneoplastic pemphigus is a severe variant with distinctive clinical and histologic features, including severe stomatitis, lichenoid skin lesions, and polymorphic erosions involving multiple mucosal surfaces; patients exhibit multiple autoantibodies beyond desmogleins (including antibodies to envoplakin, periplakin, and alpha-2-macroglobulin), and the underlying malignancy (typically lymphoproliferative) must be identified and treated.

BP presents clinically very differently from PV, with tense, intact blisters as the dominant feature rather than erosions. The characteristic lesions are firm, non-flaccid blisters that do not rupture easily with minor trauma (reflecting the subepidermal location and thicker blister roof). The blisters are well-demarcated, often with an urticarial or violaceous erythematous halo, frequently accompanied by urticarial or eczematous plaques. The typical distribution favors flexural and intertriginous areas: inner thighs, lower abdomen, axillae, antecubital fossae, and groin are classic sites, with relative sparing of the oral mucosa (in contrast to PV). When oral involvement does occur in BP, it is less extensive and less painful than in PV, and gingival involvement is characteristic. The Nikolsky sign is typically negative in BP, a key differentiating finding.

The blisters contain clear, sometimes blood-tinged fluid and when they rupture (often iatrogenically or from trauma), they leave erosions that heal more rapidly than in PV, often with post-inflammatory hyperpigmentation rather than the extensive scarring seen with PV. Pruritus is often severe and may precede visible blistering by weeks, with patients describing intense itching out of proportion to cutaneous findings; the pruritus typically responds poorly to antihistamines. Urticaria and eczematous papules frequently accompany blisters and may be the initial presentation before true blister formation occurs.

Clinical variants of BP include: (1) Localized BP (10-20% of cases) with blisters confined to lower abdomen, groin, or inner thighs; some cases show good response to topical corticosteroids; (2) Urticarial BP with prominent urticarial and eczematous lesions preceding blisters; (3) Nodular BP (rare) with large nodules and vesicles, often on the extensor surfaces; (4) Pemphigoid gestationis (formerly herpes gestationis), an HLA-DR3-associated variant occurring during pregnancy with anti-BP180 antibodies, presenting with urticarial lesions and blisters predominantly on the abdomen and flexural areas; typically resolves within months of delivery but may flare with hormonal contraceptive use.

While primarily cutaneous/mucosal diseases, severe PV can result in significant systemic consequences: (1) hypermetabolism and weight loss from inability to eat due to oral pain and extensive skin involvement; (2) electrolyte abnormalities from erosion fluid losses; (3) secondary infection of widespread erosions leading to cellulitis or sepsis; (4) esophageal involvement (10-15% of PV cases) causing dysphagia and malnutrition. BP, by contrast, rarely involves internal organs, though elderly patients with extensive BP may develop similar secondary complications.

The diagnosis of PV and BP should be suspected based on clinical presentation but requires definitive confirmation through a combination of histopathology, direct immunofluorescence, and serology. The diagnostic approach is straightforward: a patient with characteristic blistering should undergo skin biopsy immediately for histopathologic and immunofluorescence analysis, simultaneously with serum testing for anti-desmoglein antibodies.

Pemphigus Vulgaris: The characteristic histologic finding is suprabasal acantholysis—the loss of cell-to-cell adhesion occurs just above the basal cell layer, creating an intraepidermal blister. The basal cells remain attached to the basement membrane (creating the classic "tombstone" appearance where a row of basaloid cells lines the blister floor), while the acantholytic cells (Tzanck cells) float free in the blister cavity. The acantholytic cells are rounded keratinocytes with large nuclei and prominent nucleoli, resembling malignant cells (which can cause diagnostic confusion). The blister roof consists of the remaining superficial and mid-epidermal layers. A mild to moderate inflammatory infiltrate of lymphocytes and histiocytes is typically present in the dermis and around the blister. Importantly, the basement membrane remains intact, distinguishing PV from subepidermal disorders.

Bullous Pemphigoid: Histology reveals subepidermal blister formation with the blister located between the basal cell layer and the basement membrane. The epidermis is intact and forms the blister roof, while the basal keratinocytes remain attached to basement membrane fragments at the blister base. A striking inflammatory infiltrate characterized by eosinophils is typical (eosinophilic spongiosis and subepidermal inflammation), distinguishing BP from other subepidermal blistering disorders. The basement membrane is initially intact but may show focal disruption at the site of blister formation. The dermis shows edema and dense infiltration with eosinophils, neutrophils, and lymphocytes.

Direct immunofluorescence performed on perilesional tissue (biopsy taken from clinically affected but non-bullous skin at the margin of a lesion, as bullous tissue may show false-negative results) uses fluorescein-labeled antibodies to detect in vivo bound antibodies and complement at the site of pathology.

Pemphigus Vulgaris: DIF shows IgG and C3 in an intercellular pattern within the epid